The Therapeutic Effect of Diatrizoate Meglumine(Hypaque) andAdrenocorticosteroid Hormone in Sudden Sensorineural Hearing Loss.
- Author:
Yong Bae LEE
1
;
Sung Min JIN
;
Sang Ouk PARK
;
Hyun Gug KANG
;
Bo Hyung KIM
Author Information
1. Department of Otolaryngology, Kangbuk Samsung Hospital, College of Medicine, Sungkyunkwan University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Sudden sensorineural hearing loss;
Hypaque;
Steroid
- MeSH:
Bed Rest;
Diatrizoate*;
Erythrocytes;
Hearing;
Hearing Loss, Sensorineural*;
Membranes;
Retrospective Studies;
Sodium-Potassium-Exchanging ATPase;
Spasm
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
1997;40(7):990-995
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Idiopathic sudden sensorineural hearing loss(ISHL) is defined as an abrupt onset of sensorineural hearing loss without definite cause. The causes of sudden sensorineural hearing loss have not determined with precision until recently, but viral infections and vascular insufficiencies, such as vascular spasm, occlusion of sludging of erythrocytes were considered as major factors. The treatment has not been determined with precision until recently. But recently, as a effective regimen, diatrizoate meglumine(Hypaque) was introduced that fills the broken membrane pores and activated the sodium pump to restore the normal DC potential. The purpose of this study was to evaluate the effectiveness of a regimen for the treatment of the sudden sensorineural hearing loss with Hypaque, steroid and bed rest by retrospective review.
